[1] Drapeau A, Walz PC, Eide JG, Rugino AJ, Shaikhouni A, Mohyeldin A, Carrau RL, Prevedello DM. Pediatric craniopharyngioma[J]. Childs Nerv Syst, 2019, 35:2133-2145. [2] Otte A, Muller HL. Childhood-onset craniopharyngioma[J]. J Clin Endocrinol Metab, 2021, 106:e3820-3836. [3] Miao YQ, Wu D. Endocrine assessment and hormone replacement therapy in children with craniopharyngioma after operation[J]. Zhongguo Shi Yong Er Ke Za Zhi, 2020, 35:446-450.[苗玉麒, 吴迪. 儿童颅咽管瘤术后内分泌评估及激素替代治疗[J]. 中国实用儿科杂志, 2020, 35:446-450.] [4] Sarkar S, Chacko SR, Korula S, Simon A, Mathai S, Chacko G, Chacko AG. Long-term outcomes following maximal safe resection in a contemporary series of childhood craniopharyngiomas[J]. Acta Neurochir (Wien), 2021, 163:499-509. [5] Huang Z, Wu J, Qi J, Pan C, Fu J, Hong T. Risk factors associated with postoperative obesity in childhood-onset craniopharyngioma patients:a case-control study[J]. World Neurosurg, 2022, 167:e1185-1195. [6] Castle-Kirszbaum M, Shi M, Goldschlager T. Quality of life in craniopharyngioma:a systematic review[J]. World Neurosurg, 2022, 164:424-435. [7] Li D, Pan J, Peng J, Zhang S, Huang G, Zhang X, Bao Y, Qi S. Risk score for the prediction of severe obesity in pediatric craniopharyngiomas:relative to tumor origin[J]. Pediatr Res, 2018, 83:645-654. [8] Elowe-Gruau E, Beltrand J, Brauner R, Pinto G, Samara-Boustani D, Thalassinos C, Busiah K, Laborde K, Boddaert N, Zerah M, Alapetite C, Grill J, Touraine P, Sainte-Rose C, Polak M, Puget S. Childhood craniopharyngioma:hypothalamus-sparing surgery decreases the risk of obesity[J]. J Clin Endocrinol Metab, 2013, 98:2376-2382. [9] Müller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Pohl F, Sorensen N, Calaminus G; Study Committee of KRANIOPHARYNGEOM 2000. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma:results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow -up[J]. Eur J Endocrinol, 2011, 165:17-24. [10] Puget S, Garnett M, Wray A, Grill J, Habrand JL, Bodaert N, Zerah M, Bezerra M, Renier D, Pierre-Kahn A, Sainte-Rose C. Pediatric craniopharyngiomas:classification and treatment according to the degree of hypothalamic involvement[J]. J Neurosurg, 2007, 106(1 Suppl):3-12. [11] Fouda MA, Zurakowski D, Scott RM, Marcus KJ, Manley PE, Ullrich NJ, Cohen LE, Goumnerova LC. Novel predictive scoring system for morbid hypothalamic obesity in patients with pediatric craniopharyngioma[J]. Childs Nerv Syst, 2021, 37:403-410. [12] Muller HL. The diagnosis and treatment of craniopharyngioma[J]. Neuroendocrinology, 2020, 110(9/10):753-766. [13] Tosta -Hernandez PDC, Siviero -Miachon AA, da SN, Cappellano A, Pinheiro MM, Spinola-Castro AM. Childhood craniopharyngioma:a 22-year challenging follow-up in a single center[J]. Horm Metab Res, 2018, 50:675-682. [14] van Iersel L, Meijneke RWH, Schouten-van Meeteren AYN, Reneman L, de Win MM, van Trotsenburg ASP, Bisschop PH, Finken MJ, Vandertop WP, van Furth WR, van Santen HM. The development of hypothalamic obesity in craniopharyngioma patients:a risk factor analysis in a well-defined cohort[J]. Pediatr Blood Cancer, 2018, 65:e26911. [15] Subspecialty Group of Endocinologic, Hereditary and Metabolic Diseases, Society of Pediatrics, Chinese Medical Association; Subspecialty Groups of Child Health Care, Society of Pediatrics, Chinese Medical Association; Clinical Nutrition Group, Society of Pediatrics, Chinese Medical Association; Editorial Board of Chinese Journal of Pediatrics. Expert consensus on diagnosis, assessment, and management of obesity in Chinese children[J]. Zhonghua Er Ke Za Zhi, 2022, 60:507-515.[中华医学会儿科学分会内分泌遗传代谢学组, 中华医学会儿科学分会儿童保健学组, 中华医学会儿科学分会临床营养学组, 中华儿科杂志编辑委员会. 中国儿童肥胖诊断评估与管理专家共识[J]. 中华儿科杂志, 2022, 60:507-515.] [16] Dho YS, Kim YH, Se YB, Han DH, Kim JH, Park CK, Wang KC, Kim DG. Endoscopic endonasal approach for craniopharyngioma:the importance of the relationship between pituitary stalk and tumor[J]. J Neurosurg, 2018, 129:611-619. [17] Craven M, Crowley JH, Chiang L, Kline C, Malbari F, Hocking MC, McCormack SE. A survey of patient-relevant outcomes in pediatric craniopharyngioma:focus on hypothalamic obesity[J]. Front Endocrinol (Lausanne), 2022, 13:876770. [18] Klages KL, Berlin KS, Cook JL, Merchant TE, Wise MS, Mandrell BN, Conklin HM, Crabtree VM. Health-related quality of life, obesity, fragmented sleep, fatigue, and psychosocial problems among youth with craniopharyngioma[J]. Psychooncology, 2022, 31:779-787. [19] Zucchini S, Di Iorgi N, Pozzobon G, Pedicelli S, Parpagnoli M, Driul D, Matarazzo P, Baronio F, Crocco M, Iudica G, Partenope C, Nardini B, Ubertini G, Menardi R, Guzzetti C, Iughetti L, Aversa T, Di Mase R, Cassio A; Physiopathology of Growth Processes and Puberty Study Group of the Italian Society for Pediatric Endocrinology and Diabetology. Management of childhood-onset craniopharyngioma in Italy:a multicenter, 7-year follow-up study of 145 patients[J]. J Clin Endocrinol Metab, 2022, 107:e1020-1031. [20] Bogusz A, Boekhoff S, Warmuth-Metz M, Calaminus G, Eveslage M, Müller HL. Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma[J]. Endocr Connect, 2019, 8:481-492. [21] Qi S, Peng J, Pan J, Zhang X, Lu Y, Fan J, Huang G. Growth and weight of children with craniopharyngiomas based on the tumour location and growth pattern[J]. J Clin Neurosci, 2013, 20:1702-1708. [22] Yano S, Kudo M, Hide T, Shinojima N, Makino K, Nakamura H, Kuratsu J. Quality of life and clinical features of long-term survivors surgically treated for pediatric craniopharyngioma[J]. World Neurosurg, 2016, 85:153-162. [23] Guo F, Wang G, Suresh V, Xu D, Zhang X, Feng M, Wang F, Liu X, Song L. Clinical study on microsurgical treatment for craniopharyngioma in a single consecutive institutional series of 335 patients[J]. Clin Neurol Neurosurg, 2018, 167:162-172. [24] Yang L, Xie SH, Fang C, Zeng EM, Tang B, Hong T. Preservation of hypothalamic function with endoscopic endonasal resection of hypothalamus-invaded craniopharyngiomas[J]. World Neurosurg, 2019, 132:e841-851. [25] Bogusz A, Muller HL. Childhood-onset craniopharyngioma:latest insights into pathology, diagnostics, treatment, and follow-up[J]. Expert Rev Neurother, 2018, 18:793-806. [26] Cossu G, Jouanneau E, Cavallo LM, Elbabaa SK, Giammattei L, Starnoni D, Barges-Coll J, Cappabianca P, Benes V, Baskaya MK, Bruneau M, Meling T, Schaller K, Chacko AG, Youssef AS, Mazzatenta D, Ammirati M, Dufour H, Laws E, Berhouma M, Daniel RT, Messerer M. Surgical management of craniopharyngiomas in adult patients:a systematic review and consensus statement on behalf of the EANS skull base section[J]. Acta Neurochir (Wien), 2020, 162:1159-1177. [27] Müller HL, Heinrich M, Bueb K, Etavard-Gorris N, Gebhardt U, Kolb R, Sorensen N. Perioperative dexamethasone treatment in childhood craniopharyngioma:influence on short-term and long-term weight gain[J]. Exp Clin Endocrinol Diabetes, 2003, 111:330-334. Weill J, Delestret I, Dhellemmes P. [28] Vinchon M, Craniopharyngioma and hypothalamic obesity in children[J]. Childs Nerv Syst, 2009, 25:347-352. between idiopathic [29] Hannerz J, Ericson K. The relationship intracranial hypertension and obesity[J]. Headache, 2009, 49:178184. |